Lv4
660 积分 2024-01-24 加入
Three-dimensional automated muscle and adipose analysis to predict hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
7小时前
待确认
Data-driven subgroups for 3-year risk stratification of incident diabetes and complications in diabetes-free Chinese adults
1个月前
已完结
Updated Global Consensus Recommendations for Risk Stratification, TreatmentInitiation, and Response Monitoring in Metabolic Dysfunction-Associated SteatoticLiver Disease
3个月前
已完结
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
4个月前
已完结
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
4个月前
已完结
herapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
4个月前
已完结
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
4个月前
已完结
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
4个月前
已完结
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
6个月前
已完结
Validation of serum non-invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia
6个月前
已完结